Steve R. Hood

Safety and efficacy of drisapersen for the treatment of Duchenne muscular dystrophy (DEMAND II): an exploratory, randomised, placebo-controlled phase 2 study

Thomas Voit, Haluk Topaloğlu, Volker Straub et al. · The Lancet Neurology · 2014 · 293 citations

Placebo-controlled Phase 2, Medicine, Duchenne Muscular Dystrophy +5

Characterization of Rhodamine-123 as a Tracer Dye for Use In In vitro Drug Transport Assays

Samantha L. Forster, Alfred E. Thumser, Steve R. Hood et al. · PLoS ONE · 2012 · 177 citations · Full text

Molecular Biology, Analytical Ultracentrifugation, Membrane Transport +19

A Randomized, Double‐Blind, Placebo‐Controlled, First‐Time‐in‐Human Study to Assess the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of GSK3389404 in Healthy Subjects

Kelong Han, Jennifer Cremer, Robert C. Elston et al. · Clinical Pharmacology in Drug Development · 2019 · 41 citations · Full text

Molecular imaging of extracellular vesicles <i>in vitro via</i> Raman metabolic labelling

Conor C. Horgan, Anika Nagelkerke, Thomas E. Whittaker et al. · Journal of Materials Chemistry B · 2020 · 33 citations · Full text

Extracellular Vesicles, Nanomedicine, Engineering +15

The Dynamics of Compound, Transcript, and Protein Effects After Treatment With 2OMePS Antisense Oligonucleotides in mdx Mice

Ingrid E.C. Verhaart, Laura van Vliet-van den Dool, Jessica A. Sipkens et al. · Molecular Therapy — Nucleic Acids · 2014 · 32 citations · Full text

Knockout Mouse, Antisense-mediated Exon Skipping, Signal Transduction +14